The outcome of Cryptococcus neoformans intracellular pathogenesis in human monocytes

BMC Microbiology

Volumn 9, Issue , 2009, Pages

  Alvarez, Mauricio ^a   Burn, Tamika ^a   Luo, Yong ^a   Pirofski, Liise Anne ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYSACCHARIDE; BACTERIAL POLYSACCHARIDE;

ANIMAL CELL; ARTICLE; BLOOD; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL INTERACTION; CRYPTOCOCCUS NEOFORMANS; HOST; HUMAN; HUMAN CELL; MAMMAL; MONOCYTE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PREDATOR; RADIATION; SOIL; ANIMAL; BIOSYNTHESIS; CELL CYCLE; CELL LINE; CRYPTOCOCCOSIS; CYTOLOGY; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PHAGOCYTOSIS;

FILOBASIDIELLA NEOFORMANS; MAMMALIA; MURINAE;

ANIMALS; CELL CYCLE; CELL LINE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HUMANS; MICE; MONOCYTES; PHAGOCYTOSIS; POLYSACCHARIDES, BACTERIAL;

EID: 65349164198     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-9-51     Document Type: Article

References (31)

1. Cryptococccus neoformans. A Casadevall J Perfect, Washington, DC: American Society for Microbiology Press 1998
2. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. M Feldmesser Y Kress P Novikoff A Casadevall, Infect Immun 2000 68 7 4225 4237 10858240 10.1128/IAI.68.7.4225-4237.2000 (Pubitemid 30434578)
3. An innate immune system cell is a major determinant of species-related susceptibility differences to fungal pneumonia. X Shao A Mednick M Alvarez N van Rooijen A Casadevall DL Goldman, J Immunol 2005 175 5 3244 3251 16116215 (Pubitemid 41170545)
4. Interactions of fungi with phagocytes. MK Mansour SM Levitz, Curr Opin Microbiol 2002 5 4 359 365 10.1016/S1369-5274(02)00342-9 12160853
5. Cryptococcus neoformans survive and replicate in human microglia. SC Lee Y Kress ML Zhao DW Dickson A Casadevall, Lab Invest 1995 73 6 871 879 8558850 (Pubitemid 26002348)
6. Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. SC Tucker A Casadevall, Proc Natl Acad Sci USA 2002 99 5 3165 3170 11880650 10.1073/pnas.052702799 (Pubitemid 34240603)
7. Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. M Alvarez A Casadevall, Curr Biol 2006 16 21 2161 2165 10.1016/j.cub.2006.09.061 17084702
8. Expulsion of live pathogenic yeast by macrophages. H Ma JE Croudace DA Lammas RC May, Curr Biol 2006 16 21 2156 2160 10.1016/j.cub.2006.09.032 17084701
9. Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macrophages. M Alvarez A Casadevall, BMC Immunol 2007 8 1 16 17705844 10.1186/1471-2172-8-16 (Pubitemid 47471179)
10. Direct cell-to-cell spread of a pathogenic yeast. H Ma JE Croudace DA Lammas RC May, BMC Immunol 2007 8 15 17705831 10.1186/1471-2172-8-15 (Pubitemid 47423370)
11. Accidental virulence, cryptic pathogenesis, martians, lost hosts, and the pathogenicity of environmental microbes. A Casadevall LA Pirofski, Eukaryot Cell 2007 6 12 2169 2174 17951515 10.1128/EC.00308-07
12. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. JN Steenbergen HA Shuman A Casadevall, Proc Natl Acad Sci USA 2001 98 26 15245 15250 11742090 10.1073/pnas.261418798 (Pubitemid 34013999)
13. Cryptococcus neoformans virulence is enhanced after growth in the genetically malleable host Dictyostelium discoideum. JN Steenbergen JD Nosanchuk SD Malliaris A Casadevall, Infect Immun 2003 71 9 4862 4872 12933827 10.1128/IAI.71.9.4862-4872.2003 (Pubitemid 37070727)
14. Fungal virulence, vertebrate endothermy, and dinosaur extinction: is there a connection? A Casadevall, Fungal Genet Biol 2005 42 2 98 106 10.1016/j.fgb.2004.11.008 15670708
15. 'Ready made' virulence and 'dual use' virulence factors in pathogenic environmental fungi - The Cryptococcus neoformans paradigm. A Casadevall JN Steenbergen JD Nosanchuk, Curr Opin Microbiol 2003 6 4 332 337 10.1016/S1369-5274(03)00082-1 12941400 (Pubitemid 37075348)
16. Fc- and complement-receptor activation stimulates cell cycle progression of macrophage cells from G1 to S. Y Luo SC Tucker A Casadevall, J Immunol 2005 174 11 7226 7233 15905568 (Pubitemid 40705691)
17. Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans. C Retini TR Kozel D Pietrella C Monari F Bistoni A Vecchiarelli, Infect Immun 2001 69 10 6064 6073 11553544 10.1128/IAI.69.10.6064-6073.2001 (Pubitemid 32885166)
18. Monocyte dysfunction in patients with acquired immunodeficiency syndrome (AIDS) versus Cryptococcus neoformans. C Monari F Baldelli D Pietrella C Retini C Tascini D Francisci F Bistoni A Vecchiarelli, J Infect 1997 35 3 257 263 10.1016/S0163-4453(97)93042-5 9459399 (Pubitemid 28025149)
19. Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation. SM Levitz TS Harrison A Tabuni X Liu, J Clin Invest 1997 100 6 1640 1646 9294133 10.1172/JCI119688 (Pubitemid 27425792)
20. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. SM Levitz SH Nong KF Seetoo TS Harrison RA Speizer ER Simons, Infect Immun 1999 67 2 885 890 9916104 (Pubitemid 29059232)
21. The relative susceptibility of mouse strains to pulmonary Cryptococcus neoformans infection is associated with pleiotropic differences in the immune response. O Zaragoza M Alvarez A Telzak J Rivera A Casadevall, Infect Immun 2007 75 6 2729 2739 17371865 10.1128/IAI.00094-07 (Pubitemid 46870153)
22. Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines. SM Levitz TP Farrell, Infect Immun 1990 58 5 1201 1209 2182538 (Pubitemid 20151778)
23. Growth of Cryptococcus neoformans within human macrophages in vitro. RD Diamond JE Bennett, Infect Immun 1973 7 2 231 236 4697791
24. Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice. TB Kechichian J Shea M Del Poeta, Infect Immun 2007 75 10 4792 4798 17664261 10.1128/IAI.00587-07 (Pubitemid 47502148)
25. Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain. Y Liu XP Tang JC McArthur J Scott S Gartner, J Neurovirol 2000 6 Suppl 1 S70 81 10871768 (Pubitemid 30342780)
26. Kabat Database and its applications: future directions. G Johnson TT Wu, Nucleic Acids Res 2001 29 1 205 206 11125092 10.1093/nar/29.1.205 (Pubitemid 32054448)
27. Only six kingdoms of life. T Cavalier-Smith, Proc Biol Sci 2004 271 1545 1251 1262 15306349 10.1098/rspb.2004.2705 (Pubitemid 38789317)
28. J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins. S Mukherjee M Feldmesser A Casadevall, J Infect Dis 1996 173 5 1222 1231 8627076 (Pubitemid 26251467)
29. Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity. P Ralph J Prichard M Cohn, J Immunol 1975 114 2 pt 2 898 905 1089721
30. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. A Vecchiarelli C Retini C Monari C Tascini F Bistoni TR Kozel, Infect Immun 1996 64 7 2846 2849 8698522 (Pubitemid 26226860)
31. ImageJ. http://rsb.info.nih.gov/ij/